<DOC>
	<DOC>NCT01496326</DOC>
	<brief_summary>This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment of ibuprofen compared to the use of a placebo topical treatment. A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days Dosing twice daily (b.i.d.)</brief_summary>
	<brief_title>Osteoarthritis Topical Treatment</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Main Male or female patients aged at least 40 years. Primary osteoarthritis in a single knee joint, grade II/III based on the Kellgren and Lawrence classification system. Radiographic evidence consistent with osteoarthritis carried out within 6 months before screening. pain is currently not adequately controlled with a simple analgesic or an NSAID OR would necessitate treatment, but is not yet treated. Main Concomitant presence of another type of continuous pain that is more severe in intensity in comparison with the osteoarthritis target joint pain Osteoarthritis causing significant pain in any joint other than the identified knee, or contralateral knee (â‰¥ 20 mm pain) as confirmed by a separate VAS at visit 1 for any other painful joint concerned. Female patients who are pregnant or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>knee pain</keyword>
</DOC>